表紙
市場調查報告書

全球抗生素市場:2020年∼2024年的預測

Global Antibiotics Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 312950
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
全球抗生素市場:2020年∼2024年的預測 Global Antibiotics Market 2020-2024
出版日期: 2020年03月17日內容資訊: 英文 120 Pages
簡介

全球抗生素市場在預測期間內預計將以3%的年複合成長率增長,2024年達到44億4,000萬美元的規模。該市場成長的主要因素有感染疾病的盛行率上升。此外人們對各種疾病及其治療方法的認識不斷提高,有望在預測期內支持市場增長。

本報告提供全球抗生素市場的相關調查,提供市場趨勢和課題,成長要素,各用途·產品·來歷·作用機制·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2019年
  • 市場預測:2019-2024年的預測

波特的五力分析

市場區隔:各產品

  • 市場區隔
  • 比較
  • 廣域抗生素
  • 狹域抗生素
  • 市場機會

市場區隔:各用途

  • 市場區隔
  • 比較
  • 人類用
  • 動物用
  • 市場機會

市場區隔:各來源

  • 市場區隔
  • 比較
  • 天然
  • 半合成
  • 合成
  • 市場機會

市場區隔:各作用機制

  • 市場區隔
  • 比較
  • 靜菌劑
  • 殺菌劑
  • 市場機會

客戶形勢

  • 概要

各地區形勢

  • 市場區隔
  • 比較
  • 亞太地區
  • 北美
  • 歐洲
  • 南美
  • 中東·非洲
  • 主要國家
  • 市場機會

市場成長要素,課題,及趨勢

  • 市場成長要素
  • 交易量的成長要素:需求主導的成長
  • 交易量的成長要素:供給主導的成長
  • 交易量的成長要素:外部要素
  • 交易量的成長要素-需求轉移到鄰近市場
  • 價格成長要素:通貨膨脹
  • 價格成長要素-從低價格單位轉變到高價格單位
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 形勢的創新
  • 供應商分析

交易廠商

  • 供應商的市場上地位
  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Mayne Pharma Group Ltd.
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR41323

Technavio has been monitoring the global antibiotics market 2020-2024 and it is poised to grow by USD 4.44 bn during 2020-2024, progressing at a CAGR of 3% during the forecast period. Our reports on global antibiotics market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of infectious diseases. In addition, growing awareness of various diseases and its treatment is anticipated to boost the growth of the global antibiotics market 2020-2024 as well.

Market Segmentation

Technavio's ‘ global antibiotics market 2020-2024 ’ is segmented as below:

Application:

  • Antibiotics For Human Use
  • Antibiotics For Veterinary Use

Product:

  • Broad-spectrum Antibiotics
  • Narrow-spectrum Antibiotics

Drug Origin:

  • Natural
  • Semi-synthetic
  • Synthetic

Action Mechanism:

  • Bacteriostatic
  • Bactericidal

Geographic segmentation

  • North America
  • APAC
  • Europe
  • South America
  • MEA

Key Trends for global antibiotics market 2020-2024 growth

This study identifies growing awareness of various diseases and its treatment as the prime reasons driving the global antibiotics market 2020-2024 growth during the next few years.

Prominent vendors in global antibiotics market 2020-2024

We provide a detailed analysis of around 25 vendors operating in the global antibiotics market 2020-2024, including some of the vendors such as Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Mayne Pharma Group Ltd., Merck KGaA, Pfizer Inc. and Sanofi .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product placement
  • Broad-spectrum antibiotics - Market size and forecast 2019-2024
  • Narrow-spectrum antibiotics - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by Application

  • Market segments
  • Comparison by Application placement
  • Antibiotics for human use - Market size and forecast 2019-2024
  • Antibiotics for veterinary use - Market size and forecast 2019-2024
  • Market opportunity by Application

Market Segmentation by Other 1

  • Market segments
  • Comparison by Other1 placement
  • Natural - Market size and forecast 2019-2024
  • Semisynthetic - Market size and forecast 2019-2024
  • Synthetic - Market size and forecast 2019-2024
  • Market opportunity by Other1

Market Segmentation by Other 2

  • Market segments
  • Comparison by Other2 placement
  • Bacteriostatic - Market size and forecast 2019-2024
  • Bactericidal - Market size and forecast 2019-2024
  • Market opportunity by Other2

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • APAC - Market size and forecast 2019-2024
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption
  • Vendor Analysis

Vendors covered

  • Market positioning of vendors
  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Mayne Pharma Group Ltd.
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Key Finding 8
  • 8.Key Finding 9
  • 9.Key Finding 10
  • 10.Key Finding 11
  • 11.Market in focus
  • 13.Parent market
  • 16.Market characteristics
  • 18.Offerings of vendors included in the market definition
  • 20.Market segments.
  • 25.Global - Market size and forecast 2019 - 2024 ($ billion)
  • 26.Global market: Year-over-year growth 2019 - 2024 (%)
  • 27.Five forces analysis 2019 & 2024
  • 29.Bargaining power of buyers
  • 30.Bargaining power of suppliers
  • 31.Threat of new entrants
  • 32.Threat of substitutes
  • 33.Threat of rivalry
  • 35.Market condition - Five forces 2019
  • 36.Product placement - Market share 2019-2024 (%)
  • 37.Comparison by Product placement
  • 38.Broad-spectrum antibiotics - Market size and forecast 2019-2024 ($ billion)
  • 39.Broad-spectrum antibiotics - Year-over-year growth 2019-2024 (%)
  • 40.Narrow-spectrum antibiotics - Market size and forecast 2019-2024 ($ billion)
  • 41.Narrow-spectrum antibiotics - Year-over-year growth 2019-2024 (%)
  • 42. Market opportunity by Product
  • 43.Application placement - Market share 2019-2024 (%)
  • 44.Comparison by Application placement
  • 45.Antibiotics for human use - Market size and forecast 2019-2024 ($ billion)
  • 46.Antibiotics for human use - Year-over-year growth 2019-2024 (%)
  • 47.Antibiotics for veterinary use - Market size and forecast 2019-2024 ($ billion)
  • 48.Antibiotics for veterinary use - Year-over-year growth 2019-2024 (%)
  • 49. Market opportunity by Application
  • 50.Other1 placement - Market share 2019-2024 (%)
  • 51.Comparison by Other1 placement
  • 52.Natural - Market size and forecast 2019-2024 ($ billion)
  • 53.Natural - Year-over-year growth 2019-2024 (%)
  • 54.Semisynthetic - Market size and forecast 2019-2024 ($ billion)
  • 55.Semisynthetic - Year-over-year growth 2019-2024 (%)
  • 56.Synthetic - Market size and forecast 2019-2024 ($ billion)
  • 57.Synthetic - Year-over-year growth 2019-2024 (%)
  • 58. Market opportunity by Other1
  • 59.Other2 placement - Market share 2019-2024 (%)
  • 60.Comparison by Other2 placement
  • 61.Bacteriostatic - Market size and forecast 2019-2024 ($ billion)
  • 62.Bacteriostatic - Year-over-year growth 2019-2024 (%)
  • 63.Bactericidal - Market size and forecast 2019-2024 ($ billion)
  • 64.Bactericidal - Year-over-year growth 2019-2024 (%)
  • 65. Market opportunity by Other2
  • 66.Customer landscape
  • 67.Market share by geography 2019-2024 (%)
  • 68.Geographic comparison
  • 70.APAC - Market size and forecast 2019-2024 ($ billion)
  • 71.APAC - Year-over-year growth 2019-2024 (%)
  • 73.North America - Market size and forecast 2019-2024 ($ billion)
  • 74.North America - Year-over-year growth 2019-2024 (%)
  • 76.Europe - Market size and forecast 2019-2024 ($ billion)
  • 77.Europe - Year-over-year growth 2019-2024 (%)
  • 79.South America - Market size and forecast 2019-2024 ($ billion)
  • 80.South America - Year-over-year growth 2019-2024 (%)
  • 82.MEA - Market size and forecast 2019-2024 ($ billion)
  • 83.MEA - Year-over-year growth 2019-2024 (%)
  • 85.Key leading countries
  • 86.Market opportunity by geography ($ billion)
  • 87.Impact of drivers and challenges
  • 88.Vendor landscape
  • 90.Landscape disruption
  • 92.Industry risks
  • 94.Vendors covered
  • 96.Market positioning of vendors
  • 98.Abbott Laboratories - Overview
  • 99.Abbott Laboratories - Business segments
  • 100.Abbott Laboratories - Key offerings
  • 101.Abbott Laboratories - Key customers
  • 102.Abbott Laboratories - Segment focus
  • 104.AbbVie Inc. - Overview
  • 105.AbbVie Inc. - Business segments
  • 106.AbbVie Inc. - Key offerings
  • 107.AbbVie Inc. - Key customers
  • 108.AbbVie Inc. - Segment focus
  • 110.AstraZeneca Plc - Overview
  • 111.AstraZeneca Plc - Business segments
  • 112.AstraZeneca Plc - Key offerings
  • 113.AstraZeneca Plc - Key customers
  • 114.AstraZeneca Plc - Segment focus
  • 116.Bayer AG - Overview
  • 117.Bayer AG - Business segments
  • 118.Bayer AG - Key offerings
  • 119.Bayer AG - Key customers
  • 120.Bayer AG - Segment focus
  • 122.F. Hoffmann-La Roche Ltd. - Overview
  • 123.F. Hoffmann-La Roche Ltd. - Business segments
  • 124.F. Hoffmann-La Roche Ltd. - Key offerings
  • 125.F. Hoffmann-La Roche Ltd. - Key customers
  • 126.F. Hoffmann-La Roche Ltd. - Segment focus
  • 128.Johnson & Johnson - Overview
  • 129.Johnson & Johnson - Business segments
  • 130.Johnson & Johnson - Key offerings
  • 131.Johnson & Johnson - Key customers
  • 132.Johnson & Johnson - Segment focus
  • 134.Mayne Pharma Group Ltd. - Overview
  • 135.Mayne Pharma Group Ltd. - Business segments
  • 136.Mayne Pharma Group Ltd. - Key offerings
  • 137.Mayne Pharma Group Ltd. - Key customers
  • 138.Mayne Pharma Group Ltd. - Segment focus
  • 140.Merck KGaA - Overview
  • 141.Merck KGaA - Business segments
  • 142.Merck KGaA - Key offerings
  • 143.Merck KGaA - Key customers
  • 144.Merck KGaA - Segment focus
  • 146.Pfizer Inc. - Overview
  • 147.Pfizer Inc. - Business segments
  • 148.Pfizer Inc. - Key offerings
  • 149.Pfizer Inc. - Key customers
  • 150.Pfizer Inc. - Segment focus
  • 152.Sanofi - Overview
  • 153.Sanofi - Product and service
  • 154.Sanofi - Key offerings
  • 155.Sanofi - Key customers
  • 156.Sanofi - Segment focus
  • 158.Currency conversion rates for US$
  • 159.Research Methodology
  • 160.Validation techniques employed for market sizing
  • 161.Information sources
  • 162. List of abbreviations